These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 156196)

  • 1. Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.
    Aoki N; Saito H; Kamiya T; Koie K; Sakata Y; Kobakura M
    J Clin Invest; 1979 May; 63(5):877-84. PubMed ID: 156196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 2-antiplasmin deficiency in a Sudanese child: a case report.
    Mohammed BAB
    J Med Case Rep; 2021 May; 15(1):238. PubMed ID: 33957960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital deficiency of alpha 2-plasmin inhibitor in three sisters.
    Yoshioka A; Kamitsuji H; Takase T; Iida Y; Tsukada S; Mikami S; Fukui H
    Haemostasis; 1982; 11(3):176-84. PubMed ID: 7095605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin.
    Kluft C; Vellenga E; Brommer EJ; Wijngaards G
    Blood; 1982 Jun; 59(6):1169-80. PubMed ID: 6177359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
    Sakata Y; Aoki N
    J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hemorrhagic tendency in heterozygous alpha 2-antiplasmin deficiency.
    Kordich L; Feldman L; Porterie P; Lago O
    Thromb Res; 1985 Dec; 40(5):645-51. PubMed ID: 4089832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bleeding disorder due to deficiency of alpha 2-antiplasmin.
    Miles LA; Plow EF; Donnelly KJ; Hougie C; Griffin JH
    Blood; 1982 Jun; 59(6):1246-51. PubMed ID: 7082827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
    Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
    J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha2-plasmin-inhibitor deficiency (Miyasato disease).
    Koie K; Kamiya T; Ogata K; Takamatsu J
    Lancet; 1978 Dec 23-30; 2(8104-5):1334-6. PubMed ID: 82839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of accelerated fibrinolysis in liver disease.
    Francis RB; Feinstein DI
    Haemostasis; 1984; 14(6):460-5. PubMed ID: 6534818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory spectrum of alpha 2-plasmin inhibitor.
    Saito H; Goldsmith GH; Moroi M; Aoki N
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2013-7. PubMed ID: 156364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency.
    Gidley GN; Holle LA; Burthem J; Bolton-Maggs PHB; Lin FC; Wolberg AS
    Blood Adv; 2018 May; 2(10):1076-1088. PubMed ID: 29760205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blind spots of the diagnostic hemostasis screen].
    Levi M; Peters M; Briët E
    Ned Tijdschr Geneeskd; 2000 Mar; 144(10):457-60. PubMed ID: 10726152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological role of alpha 2-plasmin inhibitor in rats.
    Kumada T; Abiko Y
    Thromb Res; 1984 Oct; 36(2):153-63. PubMed ID: 6506034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hitherto undescribed plasma factor acting at the contact phase of blood coagulation (Flaujeac factor): case report and coagulation studies.
    Lacombe MJ; Varet B; Levy JP
    Blood; 1975 Nov; 46(5):761-8. PubMed ID: 1174709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory evaluation of a bleeding patient.
    Wallerstein RO
    West J Med; 1989 Jan; 150(1):51-8. PubMed ID: 2660407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis.
    Matsumoto T; Nogami K; Shima M
    Thromb Haemost; 2013 Oct; 110(4):761-8. PubMed ID: 24072166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.
    Schleef RR; Higgins DL; Pillemer E; Levitt LJ
    J Clin Invest; 1989 May; 83(5):1747-52. PubMed ID: 2496147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.